Michael Seiberling

METABOLISM AND DISPOSITION OF IMATINIB MESYLATE IN HEALTHY VOLUNTEERS

Hans-Peter Gschwind, Ulrike Pfaar, Felix Waldmeier et al. · Drug Metabolism and Disposition · 2005 · 219 citations

Absolute Bioavailability of Imatinib (Glivec®) Orally versus Intravenous Infusion

Bin Peng, Catherine Dutreix, Günther H. Mehring et al. · The Journal of Clinical Pharmacology · 2004 · 166 citations

Imatinib Absorption, Pharmaceutical Science, Healthy Subjects +12

Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects

Ann E. Bolton, Bin Peng, Martine Hubert et al. · Cancer Chemotherapy and Pharmacology · 2004 · 156 citations

Healthy Subjects, Imatinib Mesylate, Pharmacological Study +6

Pharmacokinetic interaction between ketoconazole and imatinib mesylate (Glivec) in healthy subjects

Catherine Dutreix, Bin Peng, Guenther H. Mehring et al. · Cancer Chemotherapy and Pharmacology · 2004 · 152 citations

Molecular Pharmacology, Therapeutic Drug Monitoring, Healthy Subjects +7

Absorption, Distribution, Metabolism, and Elimination of the Direct Renin Inhibitor Aliskiren in Healthy Volunteers

Felix Waldmeier, Ulrike Glaenzel, B. Wirz et al. · Drug Metabolism and Disposition · 2007 · 127 citations